Clinical Study of the Treatment of Klebsiella pneumoniae with Comprehensive Nursing Intervention Combined with New Nano Silver

2020 ◽  
Vol 20 (10) ◽  
pp. 6063-6069
Author(s):  
Shenghua Cao ◽  
Xiaoqian Wu ◽  
Jianling Zhao ◽  
Xinhong Jia
Keyword(s):  
Klebsiella Pneumoniae ◽  
Nursing Intervention ◽  
Bactericidal Effect ◽  
Inhibitory Effect ◽  
Control Group ◽  
Nano Silver ◽  
Clinical Nurses ◽  
Microdilution Method ◽  
Broth Microdilution Method ◽  
Management Modes

To investigate the inhibitory effect of new nano silver (nAg-NPs) on Klebsiella pneumoniae producing extended spectrum β-lactamases (EBLs). Clinical interventions are mainly directed to inpatients, or patients with obvious discomfort, symptoms, and signs needing outpatient examination, referral, and clear diagnosis. We randomly selected 88 patients from the rehabilitation department of our hospital from November 2017 to June 2019, and divided them into observation and control groups by drawing lots. Taking ESBL K. pneumoniae as the research object, the bactericidal effect of nAg-NPs was determined using the coating method; the minimal inhibitory concentration (MIC) was measured using the broth microdilution method, and the mechanism of action of nAg-NPs on ESBL K. pneumoniae was evaluated by electron microscopy. After the implementation of different nursing management modes, the incidence of risk events in the observation group was significantly lower than that in the control group, and nursing satisfaction was significantly higher than that in the control group. nAg-NPs (≥0.5 g/mL) had 100% bactericidal effect on ESBL K. pneumoniae, 0.05 g/mL nAg-NPs had obvious bactericidal effect on ESBL K. pneumoniae, 5 g/mL nAg-NPs had obvious bactericidal effect on ESBL K. pneumoniae for 5, 15, 30 and 60 min. Additionally, nAg-NPs showed 3.12 g/mL of MIC. Furthermore, nAg-NPs had a significant effect on the morphology of K. pneumoniae. nAg-NPs shows obvious inhibitory effect on ESBL K. pneumoniae. These results will provide an experimental basis for the further study and clinical application of nAg-NPs with the help of clinical nurses.

scholarly journals Susceptibility to antibiotic combinations of Klebsiella pneumoniae and Acinetobacter baumannii strains isolated from COVID-19 patients

2021 ◽  
Vol 18 (4) ◽  
pp. 33-40
Author(s):  
D. V. Tapalski ◽  
E. V. Karpova
Keyword(s):  
Klebsiella Pneumoniae ◽  
Bactericidal Activity ◽  
Antibacterial Effect ◽  
Bactericidal Effect ◽  
Bacteriostatic Activity ◽  
Broth Microdilution ◽  
Colistin Resistance ◽  
Microdilution Method ◽  
Carbapenem Resistant ◽  
Broth Microdilution Method

Objective. To assess the susceptibility of K.pneumoniae and A.baumanii strains isolated from hospitalized COVID-19 patients to antibiotics and their combinations.Materials and methods. The minimum inhibitory concentrations (MICs) of meropenem and colistin were determined for 47 A.baumannii and 51K.pneumoniaestrains isolated from the hospitalized COVID-19 patients by the broth microdilution method. The susceptibility to 11 antibiotic combinations was assessed using the method of multiple combination bactericidal testing.Results. Colistin resistance was detected in 31.9 % of A.baumannii strains (MIC50 — 0.5 mg/l, MIC90 — 16 mg/l) and in 80.4 % of K.pneumoniaestrains (MIC50 — 16 mg/l, MIC90 — 256 mg/l). It has been shown that double antibiotic combinations with the inclusion of colistin exhibit bactericidal or bacteriostatic activity against 76.6–87.2 % of A.baumannii strains. Combinations with the addition of meropenem, colistin and macrolides exhibited bactericidal activity against 78.4–80.4 % of K.pneumoniae strains. Combinations of two carbapenems were not active, the combination of meropenem-colistin had a bactericidal effect only in 13.7 % of K.pneumoniae strains.Conclusion. Widespread colistin resistance was found in carbapenem-resistant K.pneumoniae and A.baumannii strains isolated from the hospitalized COVID-19 patients. The combinations of antibiotics that have a synergistic antibacterial effect in their pharmacokinetic/pharmacodynamic concentrations have been determined.

scholarly journals Mortality of Pandrug-Resistant Klebsiella pneumoniae Bloodstream Infections in Critically Ill Patients: A Retrospective Cohort of 115 Episodes

Antibiotics ◽  
2021 ◽  
Vol 10 (1) ◽  
pp. 76
Author(s):  
Matthaios Papadimitriou-Olivgeris ◽  
Christina Bartzavali ◽  
Alexandra Georgakopoulou ◽  
Fevronia Kolonitsiou ◽  
Chrisavgi Papamichail ◽  
...  
Keyword(s):  
Septic Shock ◽  
Klebsiella Pneumoniae ◽  
Critically Ill ◽  
Critically Ill Patients ◽  
Primary Outcome ◽  
Bloodstream Infections ◽  
Microdilution Method ◽  
Broth Microdilution Method ◽  
Carbapenemase Gene ◽  
Comorbidity Index

Background: The increased frequency of bacteraemias caused by pandrug-resistant Klebsiella pneumoniae (PDR-Kp) has significant implications. The aim of the present study was to identify predictors associated with mortality of PDR-Kp bacteraemias. Methods: Patients with monomicrobial bacteraemia due to PDR-Kp were included. K. pneumoniae was considered PDR if it showed resistance to all available groups of antibiotics. Primary outcome was 30-day mortality. Minimum inhibitory concentrations (MICs) of meropenem, tigecycline, fosfomycin, and ceftazidime/avibactam were determined by Etest, whereas for colistin, the broth microdilution method was applied. blaKPC, blaVIM, blaNDM, and blaOXA genes were detected by PCR. Results: Among 115 PDR-Kp bacteraemias, the majority of infections were primary bacteraemias (53; 46.1%), followed by catheter-related (35; 30.4%). All isolates were resistant to tested antimicrobials. blaKPC was the most prevalent carbapenemase gene (98 isolates; 85.2%). Thirty-day mortality was 39.1%; among 51 patients with septic shock, 30-day mortality was 54.9%. Multivariate analysis identified the development of septic shock, Charlson comorbidity index, and bacteraemia other than primary or catheter-related as independent predictors of mortality, while a combination of at least three antimicrobials was identified as an independent predictor of survival. Conclusions: Mortality of PDR-Kp bloodstream infections was high. Administration of at least three antimicrobials might be beneficial for infections in critically ill patients caused by such pathogens.

scholarly journals A Comparative antimicrobial analysis of Tridax procumbens L. various extracts on waterborne bacterial pathogens

2016 ◽  
Vol 5 (3) ◽  
pp. 22-26 ◽  
Author(s):  
Madhu Pandey ◽  
Anand Pandey ◽  
Rajesh Kumar ◽  
Ashutosh Pathak ◽  
Anupam Dikshit
Keyword(s):  
Antibacterial Agent ◽  
Bacterial Pathogens ◽  
Bacterial Species ◽  
Pharmaceutical Journal ◽  
Bactericidal Effect ◽  
Microdilution Method ◽  
Potential Source ◽  
Tridax Procumbens ◽  
Broth Microdilution Method ◽  
Water Borne

The present study focussed on the bactericidal effect of Tridax procumbens L. against water borne bacterial pathogens. The bacterial species used in present study were Escherichia coli, Vibrio cholerae, Salmonella typhimurium and Klebsiella pneumoniae, which cause serious diseases like Diarrhoea, Cholera, Salmonellosis, Pneumonia, etc. CLSI recommended broth microdilution method was used in this study for assessing the antibacterial efficacy of the candidate plant extract. Results were depicted in the form of IC50 (mg/ml) and MIC (mg/ml) values. On the basis of this study it can be interpreted that Tridax procumbens L. proved to be a very potential source of antibacterial agent against some water borne bacterial.Pandey et al., International Current Pharmaceutical Journal, February 2016, 5(3): 22-26

scholarly journals Anti Bacterial Activity of Lavandula Extracts, Pathogen and Probiotics Bacteria

2021 ◽  
Author(s):  
Asal khodagholi ◽  
Mahdieh Soltani ◽  
Mohammad Mehdi Akbarin ◽  
Zahra Farjami
Keyword(s):  
Food Industry ◽  
Herbal Product ◽  
Inhibitory Effect ◽  
Bacterial Activity ◽  
Broth Microdilution ◽  
Time Consumption ◽  
Microdilution Method ◽  
Broth Microdilution Method ◽  
Long Time ◽  
Bacterial Effect

Abstract Introduction: Herbs of the lavender genus are widely used today as anti-bacterial drugs in traditional medicine. Lavandula angustifolia (LA) is endemic in the Iberian Peninsula and common in Iran that belongs to the Lamiaceae family. Lavandula oils, well known for their scent and aroma, have been used in the perfumery and food industry for many years, therefore the aim of this study is the assessment of the anti-bacterial effect of LA extracts against pathogens and non-pathogen bacteria. Methods: 96-well microplates MICs were determined by the broth microdilution method. Five Serial dilutions from 50 to 1 μg/mL concentrations were admitted for all bacteria which include: Escherichia Coli ATCC 25922, Enterococcus faecalis ATCC 29212, Pseudomonas aeruginosa ATCC 27853 and Staphylococcus aureus ATCC 25923, and Probiotics complex. Results: LA watery extract demonstrate the statically inhibitory effect in just 50 g/L concentration against E.Coli, E. Faecalis, Pu, and Probiotic p= 0.024, 0.025, 0.004, and 0.012 respectively, whereas this concentration was 1g/L for Staph. aureus p=0.026. LA alcohol extracts display the same effect in 1g/L for all bacteria p= 0.000.Conclusion: Our results showed that LA in both watery and Alcohol extractions can inhibit both pathogenic and non-pathogen bacteria whereas active compounds are alcohol soluble. Long-time consumption of LA in the herbal product could disrupt normal bacteria of the gastrointestinal system.

scholarly journals Chemical Composition, and Evaluation of Antibacterial，Antibiofilm and Synergistic Effects with Conventional Antibiotics of Essential Oil from Mallotus repandus

2021 ◽  
Vol 15 (4) ◽  
pp. 324-329
Author(s):  
Pengxiang Lai ◽  
Xin-Chen Zhang ◽  
Lin Zhu ◽  
Xin-Yu Li ◽  
Li-Chuan Liu
Keyword(s):  
Essential Oil ◽  
Biofilm Formation ◽  
Synergistic Effects ◽  
Antibacterial Properties ◽  
Good Alternative ◽  
Bactericidal Effect ◽  
Bacterial Strains ◽  
Microdilution Method ◽  
Broth Microdilution Method ◽  
Mallotus Repandus

The essential oil (EO) of aerial parts of Mallotus repandus (Willd.) Muell. Arg. was extracted by hydrodistillation and characterized by GC/FID and GC/MS. Fifty-one compounds comprising 97.1% of the EO were identified, of which α-humulene (18.7%), β-selinene (12.8%), aciphyllene (10.7%), (E)-caryophyllene (8.4%), α-copaene (5.5%), humulene epoxide II (4.9%) and caryophyllene oxide (4.3%) were the major compounds. The EO was evaluated for antibacterial properties using broth microdilution method and crystal-violet static biofilm formation assay. The M. repandus EO possessed a bactericidal effect against tested gram-positive bacteria strains (MIC = MBC: 0.05-0.10 mg/mL). Further, the EO showed the ability to inhibit the biofilm formation of Staphylococcus aureus. In addition, the potential synergistic effect was assessed by checkerboard method. Combination of the M. repandus EO with Streptomycin showed synergistic effects against the tested bacterial strains. This study demonstrates that M. repandus EO could be further explored as good alternative for potential pharmaceuticals.

scholarly journals Synergistic Antibiofilm Efficacy of Thymol and Piperine in Combination with Three Aminoglycoside Antibiotics against Klebsiella pneumoniae Biofilms

2021 ◽  
Vol 2021 ◽  
pp. 1-8
Author(s):  
Borel Bisso Ndezo ◽  
Christian Ramsès Tokam Kuaté ◽  
Jean Paul Dzoyem
Keyword(s):  
Klebsiella Pneumoniae ◽  
Biofilm Formation ◽  
Inhibitory Concentration ◽  
Alternative Therapy ◽  
Aminoglycoside Antibiotics ◽  
Antibiofilm Activity ◽  
Promising Alternative ◽  
Microdilution Method ◽  
Fold Reduction ◽  
Broth Microdilution Method

Background. Thymol and piperine are two naturally occurring bioactive compounds with several pharmacological activities. In this study, their antibiofilm potential either alone or in combination with three aminoglycoside antibiotics was evaluated against a biofilm of Klebsiella pneumoniae. Methods. Determination of antimicrobial susceptibility was performed using the broth microdilution method. Biofilm formation was evaluated by the microtiter plate method. Antibiofilm activity was determined using 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium-bromide (MTT) assay. The combination studies were performed by the checkerboard microdilution method. Results. The minimum biofilm inhibitory concentration (MBIC) of streptomycin was reduced by 16- to 64-fold when used in combination with thymol, while the MBIC of kanamycin was reduced by 4-fold when combined with piperine. The minimum biofilm eradication concentration (MBEC) values of streptomycin, amikacin, and kanamycin were, respectively, 16- to 128-fold, 4- to 128-fold, and 8- to 256-fold higher than the planktonic minimum inhibitory concentration (MIC). Thymol combined with streptomycin or kanamycin showed synergic effects against the preformed biofilm with 16- to 64-fold reduction in the minimum biofilm eradication concentration values of each antibiotic in combination. Piperine acted also synergically with kanamycin with an 8- to 16-fold reduction in the minimum biofilm eradication concentration values of kanamycin in combination. Conclusion. The association of thymol with antibiotics showed a strong synergistic effect both in the inhibition of biofilm formation and the destruction of the preformed biofilm of K. pneumoniae. This study suggests that a combination of thymol with streptomycin, amikacin, or kanamycin could be a promising alternative therapy to overcome the problem of K. pneumoniae biofilm-associated infections.

Antimicrobial activity and total content of polyphenols of Rheum L. species growing in Poland

2010 ◽  
Vol 5 (6) ◽  
pp. 814-820 ◽  
Author(s):  
Urszula Kosikowska ◽  
Helena Smolarz ◽  
Anna Malm
Keyword(s):  
Total Content ◽  
Inhibitory Effect ◽  
Microdilution Method ◽  
Broth Microdilution Method ◽  
Rheum Rhaponticum ◽  
Rheum Undulatum ◽  
In Vitro Antibacterial Activity ◽  
Ethanol Extracts ◽  
Staphylococcus Spp

AbstractIn the crude ethanol extracts obtained from the rhizome and roots of Rheum palmatum L., Rheum undulatum L. and Rheum rhaponticum L. growing in Poland concentration of polyphenols ranged from 46.11 to 76.45 mg/g. Concentration of tannins ranged from 7.07% to 8.67%, while anthracene derivatives and anthraquinones varied by species - R. palmatum measured 36.3 and 34 mg/g, while R. undulatum or R. rhaponticum did not exceed 20.4 and 18.1 or 19.8 mg/g and 16.6 mg/g, respectively. Using a broth microdilution method it was found that all of the Rheum spp. extracts were more active against reference strains of Gram-positive bacteria (Staphylococcus spp.) than against those of Gram-negative bacteria (Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis). The strongest inhibitory effect against Staphylococcus spp. was exerted by R. undulatum extract with MIC = 125–250 μg/mL. The moderate in vitro antibacterial activity of R. undulatum suggests that this plant, often used in the European cuisine to improve flavour, may be also important and useful as an alternative or auxiliary medicine remedy in the treatment of uncomplicated superficial infections caused especially by clinically important staphylococci, potentially pathogenic S. aureus or opportunistic S. epidermidis.

scholarly journals Resistance phenotype and molecular epidemiology of Carbapenem-resistant Klebsiella pneumoniae isolates in Shanghai

2020 ◽  
Author(s):  
Jue Zhang ◽  
Wenxia Zhang ◽  
Hongyou Chen ◽  
Chen Chen ◽  
Junhao Chen ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Klebsiella Pneumoniae ◽  
Molecular Epidemiology ◽  
Genetic Relatedness ◽  
Control Strategies ◽  
Microdilution Method ◽  
Carbapenem Resistant ◽  
Broth Microdilution Method ◽  
Polymerase Chain ◽  
Relationship Of

Abstract Background: The emergence and wide global spread of carbapenem-resistant Klebsiella pneumoniae (CRKP) isolates are of great concern, and the aim of this study was to investigate drug resistance, molecular epidemiology, and genetic relationship of CRKP isolates from patients in Shanghai, China. Methods: A retrospective study was conducted from April 2018 to July 2019, and a total of 133 CRKP isolates were collected. Antimicrobial susceptibility was determined by VITEK-2 automated microbiology analyzer platform (bioMérieux, France) and the broth microdilution method. Polymerase chain reaction (PCR) assays were used to investigate the presence of drug resistance genes. A modified carbapenem inactivation method (mCIM) was performed to detect carbapenemases. Multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE) were conducted for genetic relatedness of 50 CRKP isolates selected. Results: Among 670 isolates of K. pneumoniae, 133 (19.85%) strains were identified as carbapenem-resistant K. pneumoniae (CRKP), of which, 76.69% (102/133) strains were isolated from ICUs. All the 133 CRKP isolates were found to be carbapenemase-producers and harbor blaKPC-2 gene. No other carbapenemase genes of blaNDM, blaOXA−48, blaVIM, and blaIMP were detected. Furthermore, β-lactamase genes of blaSHV, blaCTX, and blaTEM were the most common resistance-associated genes among these KPC-2 producing isolates. All the 133 CRKP strains displayed more than 95% of resistance to cephalosporins and carbapenems, except for gentamicin, Trimethoprim-sulfamethoxazole, amikacin, tigecycline and colistin. The most common sequence type was ST11, accounting for 90.0% of the 50 CRKP selected, followed by ST15 (10%). PFGE analysis clustered the 50 KPC-2-producing isolates into seven (A-G) distinct clonal clusters at 85% cut off. Of which, cluster A and G were the two major clusters, accounting for the majority of the strains collected in emergency ICU and neurosurgical ICU. And all the strains of cluster D and E were collected in cardiothoracic surgery ICU, expect for one strain collected in one outpatient. Conclusion: The KPC-2-producing K.pneumoniae belonged to ST11 was widely disseminated in ICUs, and active and effective surveillance of infection control strategies was initiated to limit the spread of CRKP strains.

scholarly journals In Vitro Activities of Ceftazidime–Avibactam and Aztreonam–Avibactam at Different Inoculum Sizes of Extended-Spectrum β-Lactam-Resistant Enterobacterales Blood Isolates

Antibiotics ◽  
2021 ◽  
Vol 10 (12) ◽  
pp. 1492
Author(s):  
Moonsuk Bae ◽  
Taeeun Kim ◽  
Joung Ha Park ◽  
Seongman Bae ◽  
Heungsup Sung ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Klebsiella Pneumoniae ◽  
In Vitro Activity ◽  
Broth Microdilution ◽  
Microdilution Method ◽  
Extended Spectrum ◽  
Broth Microdilution Method ◽  
Tertiary Center ◽  
Inoculum Effect

β-lactam–avibactam combinations have been proposed as carbapenem-sparing therapies, but little data exist on their in vitro activities in infections with high bacterial inocula. We investigated the in vitro efficacies and the inoculum effects of ceftazidime–avibactam and aztreonam–avibactam against extended-spectrum β-lactam-resistant Enterobacterales blood isolates. A total of 228 non-repetitive extended-spectrum β-lactam-resistant Escherichia coli and Klebsiella pneumoniae blood isolates were prospectively collected in a tertiary center. In vitro susceptibilities to ceftazidime, aztreonam, meropenem, ceftazidime–avibactam, and aztreonam–avibactam were evaluated by broth microdilution method using standard and high inocula. An inoculum effect was defined as an eightfold or greater increase in MIC when tested with the high inoculum. Of the 228 isolates, 99% were susceptible to ceftazidime–avibactam and 99% had low aztreonam–avibactam MICs (≤8 mg/L). Ceftazidime–avibactam and aztreonam–avibactam exhibited good in vitro activities; MIC50/MIC90 values were 0.5/2 mg/L, 0.125/0.5 mg/L, and ≤0.03/0.25 mg/L, respectively, and aztreonam–avibactam was more active than ceftazidime–avibactam. The frequencies of the inoculum effect with ceftazidime–avibactam and aztreonam–avibactam were lower than with meropenem (14% vs. 38%, p < 0.001 and 30% vs. 38%, p = 0.03, respectively). The β-lactam-avibactam combinations could be useful as carbapenem-sparing strategies, and aztreonam–avibactam has the better in vitro activity but is more subject to the inoculum effect than ceftazidime–avibactam.

scholarly journals In Vitro Antifungal Activities of Sambucus ebulus Against Candida Species Using the Standard Protocol CLSI-M27-S3

2021 ◽  
Vol 2 (1) ◽  
pp. 25-29
Author(s):  
Arefeh Hosseini ◽  
Soham Ansari
Keyword(s):  
Inhibitory Effect ◽  
Herbal Extract ◽  
Total Consumption ◽  
Suitable Alternative ◽  
Chemical Treatments ◽  
Microdilution Method ◽  
Sambucus Ebulus ◽  
Broth Microdilution Method ◽  
Repeated Use

Background: The most prevalent fungal infection in the mouth is Candidiasis, which causes various problems for patients. Chemical treatments such as nystatin are the most common methods that are locally used for the mouth that tastes bitter. The repeated use of this method 4 times a day and its preparation during the total consumption lead to patients’ dissatisfaction. Herbal treatments due to less medicinal side effects while having equal effects can be a suitable alternative to chemical treatments. Accordingly, this research focused on evaluating the effect of the herbal extract of the antifungal palm on the types of Candida and then comparing it with Nystatin. Methods: To this end, the effect of the herbal extract of antifungal palm on 4 types of Candida (i.e., albicans, glabrata, tropicalis, and parapsilosis) was investigated, and then the results were compared with that of nystatin, which is diagnosed by the broth microdilution method. The result of the study is descriptive, and minimum inhibitory concentration (MIC) in the blue palm herbal extract was studied in comparison with nystatin for 20 isolated Candida. Results: Based on the result, MIC in the palm herbal extract was (mL/mg) 0.25-0.5 while the inhibitory effect of nystatin growth in this type was 0.125-0.5 (mg/L), and the MIC of the remaining types of Candida, including tropicalis, glabrata, and parapsilosis was 1-0.5 (mg/mL), 0.5-2, and 0.5-1. Finally, the inhibitory effect of growth (MIC) in nystatin drugs in the mentioned types was 0.5-0.25 (mg/L), 0.5-1, and 0.5-0.25. Conclusion: Overall, the activity of the antifungal palm herbal extract is suitable against the examined types of Candida, and this extract may be used as a drug or mouthwash for candidiasis patients.

Sign in / Sign up

Export Citation Format

Share Document